Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCode ▲DrugDate fromSubject
 30.4.2025KRKA, d.d., Novo mesto (KRK-2)9938DAmlessa Neo 10 mg/5 mg tablety (tbl 30x10 mg/5 mg (blis.OPA/Al/PVC//Al))5.5.2025O
 16.2.2023KRKA, d.d., Novo mesto (KRK-2)9934DAmlessa Neo 10 mg/10 mg tablety (tbl 90x10 mg/10 mg (blis.OPA/Al/PVC//Al))20.2.2023U
 13.2.2020Zentiva a.s. (ZNT-SK-2)99336GLURENORM (tbl 30x30 mg (blis.PVC/Al))13.2.2020R
 25.2.2020Zentiva a.s. (ZNT-SK-2)99336GLURENORM (tbl 30x30 mg (blis.PVC/Al))25.2.2020O
 2.3.2023Zentiva a.s. (ZNT-SK-2)99336GLURENORM (tbl 30x30 mg (blis.PVC/Al))10.3.2023R
 13.3.2023Zentiva a.s. (ZNT-SK-2)99336GLURENORM (tbl 30x30 mg (blis.PVC/Al))20.3.2023O
 4.4.2023Zentiva a.s. (ZNT-SK-2)99336GLURENORM (tbl 30x30 mg (blis.PVC/Al))4.4.2023R
 14.4.2023Zentiva a.s. (ZNT-SK-2)99336GLURENORM (tbl 30x30 mg (blis.PVC/Al))14.4.2023O
 22.2.2023KRKA, d.d., Novo mesto (KRK-2)9932DAmlessa Neo 10 mg/10 mg tablety (tbl 30x10 mg/10 mg (blis.OPA/Al/PVC//Al))27.2.2023U
 14.2.2025KRKA, d.d., Novo mesto (KRK-2)9932DAmlessa Neo 10 mg/10 mg tablety (tbl 30x10 mg/10 mg (blis.OPA/Al/PVC//Al))17.2.2025R
 17.4.2025KRKA, d.d., Novo mesto (KRK-2)9932DAmlessa Neo 10 mg/10 mg tablety (tbl 30x10 mg/10 mg (blis.OPA/Al/PVC//Al))22.4.2025O
 20.4.2023Olikla s.r.o. (OLK)9931CMoxifloxacin Olikla 5 mg/ml očné roztokové kvapky (int opo 1x5 ml (fľ.LDPE))20.4.2023R
 25.9.2023Olikla s.r.o. (OLK)9931CMoxifloxacin Olikla 5 mg/ml očné roztokové kvapky (int opo 1x5 ml (fľ.LDPE))26.9.2023O
 18.9.2025TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)9925EEltrombopag Teva 50 mg (tbl flm 28x50 mg (blis.OPA/Al/PVC))18.9.2025U
 18.9.2025TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)9917EEltrombopag Teva 25 mg (tbl flm 28x25 mg (blis.OPA/Al/PVC))18.9.2025U

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)